Bank Of New York Mellon Corp Exelixis, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$16.3 - $19.41 $49.3 Million - $58.7 Million	3,024,994 New	3,024,994 $58.7 Billion
Q4 2022 Feb 14, 2023	BUY	$14.96 - $17.39 $45.8 Million - $53.2 Million	3,061,851 New	3,061,851 $49.1 Million
Q3 2022 Nov 14, 2022	SELL	$15.68 - $22.27 $6.77 Million - $9.61 Million	-431,529 Reduced 11.99%	3,168,784 $49.7 Million
Q2 2022 Aug 15, 2022	BUY	$17.44 - $23.16 $8.21 Million - $10.9 Million	470,616 Added 15.04%	3,600,313 $75 Million
Q1 2022 May 11, 2022	BUY	$17.03 - $22.67 $4 Million - $5.32 Million	234,611 Added 8.1%	3,129,697 $71 Million
Q4 2021 Feb 11, 2022	SELL	$15.84 - $21.88 $1.2 Million - $1.65 Million	-75,582 Reduced 2.54%	2,895,086 $52.9 Million
Q3 2021 Nov 12, 2021	SELL	$16.3 - $21.14 $216,138 - $280,316	-13,260 Reduced 0.44%	2,970,668 $62.8 Million
Q2 2021 Aug 11, 2021	SELL	$17.95 - $25.56 $172,194 - $245,197	-9,593 Reduced 0.32%	2,983,928 $54.4 Million
Q1 2021 May 13, 2021	SELL	$20.53 - $25.22 $2.41 Million - $2.96 Million	-117,264 Reduced 3.77%	2,993,521 $67.6 Million
Q4 2020 Feb 09, 2021	SELL	$18.39 - $24.8 $2.01 Million - $2.71 Million	-109,460 Reduced 3.4%	3,110,785 $62.4 Million
Q3 2020 Nov 12, 2020	SELL	$20.67 - $26.94 $2.32 Million - $3.02 Million	-112,147 Reduced 3.37%	3,220,245 $78.7 Million
Q2 2020 Aug 12, 2020	BUY	$16.46 - $27.42 $180,401 - $300,523	10,960 Added 0.33%	3,332,392 $79.1 Million
Q1 2020 May 06, 2020	SELL	$14.46 - $21.8 $7.55 Million - $11.4 Million	-521,950 Reduced 13.58%	3,321,432 $57.2 Million
Q4 2019 Feb 14, 2020	BUY	$15.15 - $18.89 $1.25 Million - $1.56 Million	82,337 Added 2.19%	3,843,382 $67.7 Million
Q3 2019 Nov 07, 2019	SELL	$17.68 - $22.65 $361,679 - $463,351	-20,457 Reduced 0.54%	3,761,045 $66.5 Million
Q2 2019 Aug 12, 2019	BUY	$18.93 - $24.75 $1.36 Million - $1.78 Million	71,830 Added 1.94%	3,781,502 $80.8 Million
Q1 2019 May 14, 2019	SELL	$19.6 - $24.76 $656,306 - $829,088	-33,485 Reduced 0.89%	3,709,672 $88.3 Million
Q4 2018 Feb 11, 2019	BUY	$13.65 - $21.8 $8.78 Million - $14 Million	643,023 Added 20.74%	3,743,157 $73.6 Million
Q3 2018 Nov 09, 2018	BUY	$15.87 - $22.4 $914,254 - $1.29 Million	57,609 Added 1.89%	3,100,134 $0
Q2 2018 Aug 06, 2018	BUY	$18.56 - $22.45 $33.2 Million - $40.2 Million	1,790,454 Added 143.0%	3,042,525 $65.5 Million
Q1 2018 May 15, 2018	BUY	$22.15 - $31.89 $988,155 - $1.42 Million	44,612 Added 3.69%	1,252,071 $27.7 Million
Q4 2017 Feb 09, 2018	BUY	$24.23 - $30.93 $29.3 Million - $37.3 Million	1,207,459	1,207,459 $36.7 Million

Others Institutions Holding EXEL

# of Institutions

503

Shares Held

244M

Call Options Held

2.54M

Put Options Held

2.29M

Black Rock Inc. New York, NY

33.5M
Shares

$1.2 Billion
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

29.3M
Shares

$1.05 Billion
0.01% of portfolio
Farallon Capital Management LLC San Francisco, CA

25.4M
Shares

$913 Million
3.31% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

15.4M
Shares

$552 Million
0.63% of portfolio
State Street Corp Boston, MA

11.4M
Shares

$411 Million
0.01% of portfolio

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.6B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account